Liver Cancer Screening and Management in Primary Care: Early Detection to Improve Patient Outcomes in Rural and Underserved Communities is organized by Rural Medical Education (RME) Collaborative.
Released On: February 28, 2023
Expires On: February 28, 2024
Description:
Hepatocellular carcinoma (HCC) is the fastest-increasing cause of cancer-related deaths in the United States. While the incidence of HCC has slowed in urban areas in recent years, it continues to rise in rural areas. Patients with HCC living in rural and underserved communities are diagnosed at a later stage and are less likely to receive treatment. They also face unique challenges to care such as shortages of oncology specialists, limited treatment availability, and transportation barriers. In this CME/CE activity, expert faculty will review risk factors for HCC and current recommendations for screening and surveillance. Evidence-based guidelines for HCC treatment and strategies to improve multidisciplinary cancer care in rural and underserved settings will also be discussed.
Learning Objectives:
Upon completion of this activity, participants should be better able to:
• Apply clinical guidelines for HCC surveillance to clinical practice
• Assess the safety and efficacy of available therapies for HCC to effectively counsel patients requiring HCC care
• Discuss the role of multidisciplinary care in improving outcomes in patients with HCC
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
Talem Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.25 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved